COVID-19 vaccine breakthroughs in cancer patients on the rise due to omicron

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A study led by MedUni Vienna showed that, due to the omicron variant of COVID-19, there is an increasing number of breakthrough infections in people with cancer, especially those undergoing cancer therapy. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login